Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 479-486

  Franco, Manuel A ^a,b   Tin, Craig ^a,b   Rott, Lusijah S ^a   Vancott, John L ^c   Mcghee, Jerry R ^c   Greenberg, Harry B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; MONOCLONAL ANTIBODY; OKT 8; PERFORIN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0031060157     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.479-486.1997     Document Type: Article

References (45)

1. Bass, D. Personal communication.
2. 1a.Berke, G. 1995. The CTL's kiss of death. Cell 81:9-12.
3. Bernstein, D. I., R. I. Glass, G. Rodgers, B. L. Davidson, and D. A. Sack. 1995. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA 273:1191-1196.
4. Beutler, B., and H. C. van Huffel. 1994. Unraveling function in the TNF ligand and receptor families. Science 264:667-668.
5. Burns, J. W., A. A. Krishnaney, P. T. Vo, R. V. Rouse, L. J. Anderson, and H. B. Greenberg. 1995. Analyses of homologous rotavirus infection in the mouse model. Virology 207:143-153.
6. Burns, W. B., M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg. 1996. Novel protective effect of rotavirus VP6 specific IgA monoclonal antibodies that lack conventional neutralizing activity. Science 272:104-107.
7. + T cells. Science 270:1811-1815.
8. 6a.Dalton, D. K., M. S. Pitts, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
9. + lymphocytes. J. Virol. 64:4375-4382.
10. Dulbecco, R. 1980. The nature of viruses, p. 881-883. In B. D. Davis, R. Dulbecco. H. N. Eisen, and H. S. Ginsberg (ed.), Microbiology, 3rd ed., vol. 1. Harper and Row Publishers, Philadelphia.
11. Feng, N., J. W. Burns, L. Bracy, and H. B. Greenberg. 1994. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:7766-7773.
12. 9a.Franco, M. Unpublished data.
13. Franco, M. A., and H. B. Greenberg. 1995. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:7800-7806.
14. Franco, M. A., I. Prieto, M. Labbe, D. Poncet, C. F. Borras, and J. Cohen. 1993. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J. Gen. Virol. 74:2579-2586.
15. Glass, R. I., J. Gentsch, and J. C. Smith. 1994. Rotavirus vaccines: success by reassortment? Science 265:1389-1391.
16. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91:3764-3768.
17. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
18. Hoshino, Y., R. G. Wyatt, H. B. Greenberg, J. Flores, and A. Z. Kapikian. 1984. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque reduction neutralization. J. Infect. Dis. 149:694-702.
19. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
20. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37.
21. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256-3262.
22. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
23. Kundig, T. M., H. Hengartner, and R. M. Zinkernagel. 1993. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150:2316-2321.
24. Kyburz, D., D. E. Speiser, M. Battegay, H. Hengartner, and R. M. Zinkernagel. 1993. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Eur. J. Immunol. 23:1540-1545.
25. La Bonnardiere, C., J. Cohen, and M. Contrepois. 1981. Interferon activity in rotavirus infected newborn calves. Ann. Rech. Vet. 12:85-91.
26. Lecce, J. G., J. M. Cummins, and A. B. Richards. 1990. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. Mol. Biother. 2:211-216.
27. Leithauser, F., J. Dhein, G. Mechtersneimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K. M. Debatin, P. H. Krammer, and P. Moller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily. in normal and neoplastic cells. Lab. Invest. 69:415-429.
28. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652.
29. + cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 214:387-397.
30. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
31. Offit, P. A., and K. I. Dudzik. 1990. Rotavirus-spceific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J. Virol. 64:6325-6328.
32. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U. H. Koszinowski. 1993. Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215-2223.
33. Ramsay, A. J., J. Ruby, and I. A. Ramshaw. 1993. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14:155-157.
34. Riepenhoff-Talty, M., T. Dharakul, E. Kowalski, S. Michalak, and P. L. Ogra. 1987. Persistent rotavirus infection in mice with severe combined immunodeficiency. J. Virol. 61:3345-3348.
35. + T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 10:353-358.
36. Sarawar, S. R., M. Sangster, R. L. Coffman, and P. C. Doherty. 1994. Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J. Immunol. 153:1246-1253.
37. Schijns, V. E., B. L. Haagmans, E. O. Rijke, S. Huang, M. Aguet, and M. C. Horzinek. 1994. IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153:2029-2037.
38. Schwers, A., B. C. Vanden, M. Maenhoudt, J. M. Beduin, J. Werenne, and P. P. Pastoret. 1985. Experimental rotavirus diarrhoea in colostrum-deprived newborn calves: assay of treatment by administration of bacterially produced human interferon (Hu-IFN alpha 2). Ann. Rech. Vet. 16:213-218.
39. Smith, P. M., R. M. Wolcott, R. Chervenak. and S. R. Jennings. 1994. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virology 202:76-88.
40. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage, J. Immunol. 154:3806-3813.
41. 37a.VanCott, J. Unpublished data.
42. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854-10858.
43. Yang, Y., Z. Xiang, H. C. Ertl, and J. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.
44. Y asukawa, M., O. Nakagomi, and Y. Kobayashi. 1990. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans. Clin. Exp. Immunol. 80:49-55.
45. Young, H. A., and K. J. Hardy. 1995. Role of interferon-gamma in immune cell regulation. J. Leukocyte Biol. 58:373-381.